The use of flunarizine, a drug which has proven its efficacy in migraine, is often associated with important side effects. The aim of this paper has been to check their incidence at different dose levels (5 mg vs 10 mg). Our data confirm the occurrence of important side effects (in particular weight gain); on the other hand, they emphasize the dose-dependency of the side effects.
AmeryWKWauquierAVan NeutenJMDe ClerkFVan ReemptsJVJanssenPAJ.The anti-migrainous pharmacology of flunarizine (R 14 950), a calcium antagonist.Drug Exptl Clin Res1981;7:1–10.
2.
LouisP.A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine.Headache1981;21:235–9.
3.
LouisPSpieringsELH.Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double blind study.Cephalalgia1982;2:197–203.
4.
DiamondSShenbaumH.Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine.Headache1983;23:39–42.
5.
PeroutkaSJ.The pharmacology of calcium channel antagonist: a novel class of anti-migraine agents?Headache1983;23:278–83.
6.
CentonzeVTesauroPTrizioTMagroneDVinoMMacinagrossaGCampanozziFAltomareEAttoliniEAlbanoO.Efficacy and tolerability of flunarizine in the prophylaxis of migraine.Cephalalgia1985;5:163–8.
7.
BaldratiAAlbanoFde CarolisPSacquegnaT.Essential tremor and flunarizine: description of a case.Cephalalgia1987;7:285.
8.
ChouzaCScaramelliACaamanoJLDe MedineOAljanatiRRomeroS.Parkinsonism, tardive dyskinesia, akathisia and depression induced by flunarizine.Lancet1986;1:1303–4.
9.
MeyboomRHBFerrariMDDielemanBP.Parkinsonism, tardive dyskinesia, akathisia and depression induced by flunarizine.Lancet1986;2:282.
10.
MeyerSJHardenbergJ.Clinical effectiveness of calcium entry blockers in prophylactic treatment o migraine and cluster headache. Headache1983;23:266–77.
11.
SpieringsELH.Calcium entry blockers in treatment of migraine. In:GodfraindTVanhouttePMGovoniSPaolettiS eds Calcium entry blockers and tissue protection.New York: Raven Press1985:245–54.
12.
NatteroGSaviLDe LorenzoCBialeLTorreEAnconaM.Flunarizine in the treatment of headache.Cephalalgia1985;5:534–5.
13.
BonoGManzoniGCMartucciNSacquegnaTMicieliGNappiGAgnoliA.Flunarizine treatment in migraine syndrome: long-term follow up in common migraine and preliminary results in migraine with paroxysmal headache.Cephalalgia1985;5:538–9.
14.
SorensenPSHansenKOlesenJ.Flunarizine in common migraine prophylaxis. A double-blind, cross-over study.Cephalalgia1985;5:540–1.
15.
MannaVAgnoliAMartucciNCerboR.Protective effects of a calcium entry blocker, flunarizine on EEG pathological patterns in patients affected by common migraine.Cephalalgia1987;7:408–9.
16.
CanalPSerinanaJMArranzFJ.Multicentre study of preventive activity of flunarizine on migraine attacks.Cephalalgia1987;7:418–19.
17.
CentonzeVAttoliniEMacinagrossaGCampanozziFMagroneDTessauroPLoisyCAlbanoO.5 mg flunarizine in preventive therapy of migraine: efficacy and tolerance.Cephalalgia1985;5:536–7.
18.
.Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgies and Facial Pain.Cephalalgia1988;8(suppl 7).
19.
CentonzeVMagroneDVinoMCampanozziFMacinagrossaGCampanaleGAlbanoO.Flunarizina 10 mg vs flunarizina nella terapia preventiva della emicrania classica ed accompagnata.Farmaci1987;1/2:11–17.
20.
GovoniSTrabucchiMMagnoniMSPattainiFPaolettiR.Abnormal neurotransmitter release and calcium entry blockers. In:GodfraindTVanhouttePMGovoniS,Paoletti Reds Calcium entry blockers and tissue protection.New York: Raven Press1985:151–62.
21.
MarrannesRWauquierA.Influence of flunarizine on spreading depression.Cephalalgia1985;5:208.
22.
MarrannesRWauquierAReidKDeprinsE.Effects of drug on cortical spreading depression. In:AmeryWKWauquierA edsThe prelude to the migraine attack.Balliere Tindall1986:158–73.
23.
ManconiFMZuddasAPiccardiMPDel ZompoMCorsiniGU.Behavioural and biochemical effects of flunarizine on the dopaminergic system rodents.Cephalalgia1987;7:420–1.
24.
GodfraindTMillerRWiboM.Calcium antagonist and calcium entry blockade.Pharmacol Rev1986;38:321–416.
25.
CazalisMDNordmannJJ.Hormone release from isolated nerve endings of the rat neurohypophysis.J Physiol1987;390:55–70.
